Most Recent
Network 10 told a court Thursday it would "fiercely defend" a trade mark case brought by Fairfax Media over 10's recent rebrand and its newly approved trade mark, 10 Boss.
Medical device maker AMS has told the Federal Court that claims in a class action against it over allegedly defective pelvic mesh implants did not meet the standard for a representative proceeding.
Fundraising company Appco Group has dropped its appeal of a judge's decision to let an $85 million wage case against it move forward as a class action.
The judge overseeing a class action against American Medical Systems over allegedly defective pelvic mesh implants has rejected the medical device maker's bid to alter the start date for a sub-group of class members.
Liquidators for the collapsed Hastie Group will pursue test cases against two construction companies in their legal fight against more than two dozen major builders over tens of millions of dollars in unpaid bills, but an application is looming to halt the proceedings pending the outcome of a High Court challenge.
Medical device maker American Medical Systems, which is facing a class action over allegedly faulty pelvic mesh implants, has taken a page from the Ethicon pelvic mesh defence playbook, calling on the court to restrict the dates for group membership.
Cereal giant Sanitarium and retailer Rebel Sports are challenging a decision dismissing proceedings against a UK marketing company amid a contractual dispute over a recent joint promotional campaign.
A subsidiary of car leasing company McMillan Shakespeare faces a class action over vehicle warranties that gave the company "complete and unfettered" discretion to reject claims by customers.
Fundraising company Appco Group Australia has failed in its bid to put a massive sham contracting class action in the Federal Court on hold while it fights a ruling that let the case continue as a representative proceeding.
Lawyers on both sides of the class action against American Medical Services over pelvic mesh implants have taken steps to ensure the case proceeds with greater efficiency than the pelvic mesh class action against Johnson & Johnson, which went to an 89-day trial five years after that case was filed.